Bruce N. Jacobs Kymera Therapeutics, Inc. (KYMR) insider trading activity

KYMR Quotes by TradingView

Bruce N. Jacobs is Chief Financial Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 178,921 shares of KYMR, which is worth approximately $6.89 Million. The most recent transaction as insider was on Mar 11, 2021, when has been sold 1,805 shares (Common Stock) at a price of $2.08 per share, resulting in proceeds of $3,754. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 179K
6.15% 3M change
55.54% 12M change
Total Value Held $6.89 Million

Bruce N. Jacobs Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 11 2021
BUY
Exercise of conversion of derivative security
$3,754 $2.08 p/Share
1,805 Added 50.0%
1,805 Common Stock
Mar 08 2021
SELL
Open market or private sale
$513,000 $51.3 p/Share
10,000 Reduced 100.0%
0 Common Stock
Mar 08 2021
BUY
Exercise of conversion of derivative security
$20,800 $2.08 p/Share
10,000 Added 50.0%
10,000 Common Stock
Mar 03 2021
SELL
Open market or private sale
$899,600 $44.98 p/Share
20,000 Reduced 100.0%
0 Common Stock
Mar 03 2021
BUY
Exercise of conversion of derivative security
$41,600 $2.08 p/Share
20,000 Added 50.0%
20,000 Common Stock
BNJ

Bruce N. Jacobs

Chief Financial Officer
Watertown, MA

Track Institutional and Insider Activities on KYMR

Follow Kymera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

News

Receive news related to Kymera Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KYMR